Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Other Non-Current Assets (2016 - 2024)

Tenax Therapeutics' Other Non-Current Assets history spans 6 years, with the latest figure at $8435.0 for Q4 2017.

  • On a quarterly basis, Other Non-Current Assets fell 99.24% to $8435.0 in Q4 2017 year-over-year; TTM through Dec 2017 was $8435.0, a 99.24% decrease, with the full-year FY2017 number at $8435.0, down 99.24% from a year prior.
  • Other Non-Current Assets hit $8435.0 in Q4 2017 for Tenax Therapeutics, up from $2762.0 in the prior quarter.
  • Over the last five years, Other Non-Current Assets for TENX hit a ceiling of $1.1 million in Q4 2015 and a floor of $2762.0 in Q3 2017.
  • Historically, Other Non-Current Assets has averaged $676843.1 across 4 years, with a median of $1.1 million in 2015.
  • Biggest five-year swings in Other Non-Current Assets: changed 0.0% in 2016 and later tumbled 99.75% in 2017.
  • Tracing TENX's Other Non-Current Assets over 4 years: stood at $58262.0 in 2013, then soared by 1799.67% to $1.1 million in 2015, then changed by 0.0% to $1.1 million in 2016, then plummeted by 99.24% to $8435.0 in 2017.
  • Business Quant data shows Other Non-Current Assets for TENX at $8435.0 in Q4 2017, $2762.0 in Q3 2017, and $1.1 million in Q2 2017.